Editor LSA

Penny Stocks Active Momentum - TapImmune Inc.(OTCMKTS:TPIV), Medical Marijuana Inc(OTCMKTS:MJNA), OncoSec Medical Inc(OTCMKTS:ONCS), INTELLICELL BIOSCI(OTCMKTS:SVFC)

 

Lewes, DE -- (SBWIRE) -- 10/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: TapImmune Inc.(OTCMKTS:TPIV), Medical Marijuana Inc(OTCMKTS:MJNA), OncoSec Medical Inc(OTCMKTS:ONCS), INTELLICELL BIOSCI(OTCMKTS:SVFC).

TapImmune Inc.(OTCMKTS:TPIV) ended higher +40.58% and complete the day at $0.0097. The total number of shares changed hands during the day was 14.22 million. After opening at $0.02, the stock hit as high as $0.02. However, it traded between $0.01 and $0.16 over the last twelve months.

TapImmune Inc., a development stage company, engages in the discovery and development of immunotherapeutics for the treatment of cancer, as well as therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection.

For How Long TPIV will Fight for Profitability? Read This Trend Analysis report

Medical Marijuana Inc(OTCMKTS:MJNA) closed yesterday at $0.141, a -1.40% decrease. Around 4.06 million shares were traded, low from an-average trading volume of 10.79 million shares. The company is now valued at around $133.47 million.

Medical Marijuana, Inc. operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.

Has MJNA Found The Bottom And Ready To Gain Momentum? Find Out Here

OncoSec Medical Inc(OTCMKTS:ONCS) moved +0.78 percent higher at $0.258 and traded between $0.25 and $0.26 after opening the day at $0.26. Its performance over the last five days remained 2.79%, which stands at -26.29% for a month. Going back further than one month, 1-year performance after recent close was 21.13%.

OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States.

For How Long ONCS Gloss will Attract Investors? Find out via this report

INTELLICELL BIOSCI(OTCMKTS:SVFC) shares rose, gaining +12.73 percent to close at $0.0124. The stock is up around -93.11% this year and -93.11% for the last 12 months. Around 25.34 million shares changed hands yesterday, higher from an-average trading volume of 1.41 million shares.

IntelliCell BioSciences, Inc. operates as a regenerative medicine company primarily in the United States. The company develops novel technologies that address the regenerative, curative, and preventative conditions of disease states with unmet clinical needs, including aesthetic conditions, orthopedic and sports injuries, and pain, as well as clinical conditions, such as cardiac, gastrointestinal, periodontal, and autistic disorders.

Why Should Investors Buy SVFC After The Recent Gain? Just Go Here and Find Out

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/